Business - Briefly   

Natco widens agreement with Akom

MUMBAI: Natco Pharma has announced addition of two injectable drug products to its existing API supply and margin sharing agreement with Akom of the U.S. With this agreement, the total number of products covered under the agreement goes up to four. The two ANDA drug products are indicated for the prevention of nausea and vomiting associated with cancer chemotherapy.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

FM wants banks to re-balance credit
TCS to merge China operations
MoU to promote technology partnerships
Centre studying cut in petrol, diesel prices
Rupee loses eight paise
Sensex scales new peak
`KSFE to double business'
PNB's total business up
Study shows bank depositors prefer short-term schemes
Warehousing Corporation to take up milling operations
Tata Steel, IIM meet to focus on auto steel
RR Industries ropes in foreign partner
BHEL a national treasure: Dev
Exchange rates
Bullion rates
FDI proposals worth Rs. 250 cr. approved
Hexaware to acquire FocusFrame
SEBI directive to Wealth Sea
China's forex reserves hit $1 trillion
L. N. Mittal, new CEO of Arcelor Mittal
Abbott buys Kos Pharma
SBBJ plans additional branch in Coimbatore
Office-bearers elected
Moser Baer's R & D centre gets Ministry's nod
Natco widens agreement with Akom
Daimler unveils Mercedes-Benz E-Class
Lastech launches website for search in Tamil
Sutlej Textiles net up 125 p.c.
SolidWorks user group conference
City Square enters Chennai market
WTO compatible export subsidy for pepper to continue
Paramount Airways adds new destinations
AirTel's new handset bundle offer
Workshop on agenda for employment
Kuwait Airways announces new service
SBT Intel teens quiz competitions
KITCO declares 15 p.c. dividend
Spurt in Usha International's net profit

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu